Flemming Skjøth

Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study

Torben Bjerregaard Larsen, Flemming Skjøth, Peter Brønnum Nielsen et al. · BMJ · 2016 · 443 citations · Full text

Medicine, Cardiology, Pharmacotherapy +11

Efficacy and Safety of Dabigatran Etexilate and Warfarin in “Real-World” Patients With Atrial Fibrillation

Torben Bjerregaard Larsen, Lars Hvilsted Rasmussen, Flemming Skjøth et al. · Journal of the American College of Cardiology · 2013 · 401 citations

Medicine, Cardiology, Pharmacology +12

Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study

Peter Brønnum Nielsen, Flemming Skjøth, Mette Søgaard et al. · BMJ · 2017 · 344 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Indirect Comparisons of New Oral Anticoagulant Drugs for Efficacy and Safety When Used for Stroke Prevention in Atrial Fibrillation

Gregory Y.H. Lip, Torben Bjerregaard Larsen, Flemming Skjøth et al. · Journal of the American College of Cardiology · 2012 · 290 citations

Medicine, Cardiology, Pharmacotherapy +13

Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care

Deirdre A. Lane, Flemming Skjøth, Gregory Y.H. Lip et al. · Journal of the American Heart Association · 2017 · 282 citations · Full text

Medicine, Cardiology, Internal Medicine +13